Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Conclusions: In a real-life Western scenario (mostly in a third-line setting), cabozantinib efficacy and safety data were comparable with those reported in its registration trial. Data regarding the prognostic factors might help in patient selection and design of clinical trials.Liver Cancer
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Carcinoma | Children | Clinical Trials | Diarrhoea | Eating Disorders & Weight Management | Hepatocellular Carcinoma | Hypertension | Italy Health | Legislation | Liver | Liver Cancer | Urology & Nephrology | Weight Loss